KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short term Debt: 2018-2021

Historic Short term Debt for Twist Bioscience (TWST) over the last 4 years, with Sep 2021 value amounting to $1.6 million.

  • Twist Bioscience's Short term Debt rose 172.49% to $9.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.1 million, marking a year-over-year increase of 172.49%. This contributed to the annual value of $1.6 million for FY2021, which is 53.44% down from last year.
  • Twist Bioscience's Short term Debt amounted to $1.6 million in FY2021, which was down 53.44% from $3.3 million recorded in FY2020.
  • Over the past 5 years, Twist Bioscience's Short term Debt peaked at $3.3 million during FY2019, and registered a low of $1.6 million during FY2021.
  • For the 3-year period, Twist Bioscience's Short term Debt averaged around $2.7 million, with its median value being $3.3 million (2020).
  • In the last 5 years, Twist Bioscience's Short term Debt soared by 33.32% in 2019 and then crashed by 53.44% in 2021.
  • Twist Bioscience's Short term Debt (Yearly) stood at $2.5 million in 2018, then spiked by 33.32% to $3.3 million in 2019, then remained steady at $3.3 million in 2020, then crashed by 53.44% to $1.6 million in 2021.